These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 6112010)

  • 1. [Ketotifen and platelet aggregation: in vitro studies].
    Somma A; Cantone F; Campidonico U; Mazzeo V; Visone C; Scognamiglio A; Alise G
    Boll Chim Farm; 1980 Nov; 119(11):659-62. PubMed ID: 6112010
    [No Abstract]   [Full Text] [Related]  

  • 2. Ketotifen: a histamine release inhibitor.
    Martin U; Roemer D
    Monogr Allergy; 1977; 12():145-9. PubMed ID: 72350
    [No Abstract]   [Full Text] [Related]  

  • 3. The pharmacological properties of a new, orally active antianaphylactic compound: ketotifen, a benzocycloheptathiophene.
    Martin U; Römer D
    Arzneimittelforschung; 1978; 28(5):770-82. PubMed ID: 35171
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibition of allergen-mediated histamine release from human cells by ketotifen and oxatomide. Comparison with other H1 antihistamines.
    Radermecker M
    Respiration; 1981; 41(1):45-55. PubMed ID: 6166035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of ketotifen in bronchial asthma.
    Benos S; Karasiotos G; Kalatzi N
    Allergol Immunopathol (Madr); 1979; 7(3):223-6. PubMed ID: 38658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of histamine and H1-receptor blockaders on bacterial endotoxin-induced thrombocyte aggregation].
    Shenkman BZ
    Farmakol Toksikol; 1986; 49(2):13-5. PubMed ID: 2872081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissociation between the anti-anaphylactic and the anti-histaminic actions of ketotifen.
    Martin U; Baggiolini M
    Naunyn Schmiedebergs Arch Pharmacol; 1981 Apr; 316(2):186-9. PubMed ID: 6113552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition by ketotifen of idiosyncratic reactions to aspirin.
    Szczeklik A; Czerniawska-Mysik G; Serwonska M; Kuklinski P
    Allergy; 1980 Jul; 35(5):421-4. PubMed ID: 6108727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological models for characterizing new anti-asthmatics.
    Kumagai A; Tomioka H
    Triangle; 1978; 17(3-4):135-40. PubMed ID: 89745
    [No Abstract]   [Full Text] [Related]  

  • 10. [Ketotifene: experimental and clinical data].
    Craps L
    Schweiz Med Wochenschr; 1980 Feb; 110(6):187-91. PubMed ID: 6769157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiallergic profile of the novel H1-antihistaminic compound levocabastine.
    Tasaka K; Kamei C; Akagi M; Mio M; Shirasaka T; Chokki M
    Arzneimittelforschung; 1993 Dec; 43(12):1331-7. PubMed ID: 7511378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mepyramine inhibits platelet activating factor-induced rabbit platelet aggregation: role of intracellular histamine.
    Zeng S; Guo ZG
    Zhongguo Yao Li Xue Bao; 1997 Mar; 18(2):155-8. PubMed ID: 10072970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereoselective inhibition of human platelet aggregation by R-138727, the active metabolite of CS-747 (prasugrel, LY640315), a novel P2Y12 receptor inhibitor.
    Hasegawa M; Sugidachi A; Ogawa T; Isobe T; Jakubowski JA; Asai F
    Thromb Haemost; 2005 Sep; 94(3):593-8. PubMed ID: 16268477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of anti-allergic activities of the histamine H1 receptor antagonists epinastine, ketotifen and oxatomide in human leukocytes.
    Mita H; Shida T
    Arzneimittelforschung; 1995 Jan; 45(1):36-40. PubMed ID: 7893266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ketotifen in the treatment of diabetics with various allergic conditions.
    Dolecek R
    Pharmatherapeutica; 1981; 2(9):568-74. PubMed ID: 6115399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiplatelet and antiphagocyte activity of H1-antihistamines.
    Nosál R; Drábiková K; Jancinová V; Petríková M; Fábryová V
    Inflamm Res; 2005 Apr; 54 Suppl 1():S19-20. PubMed ID: 15928817
    [No Abstract]   [Full Text] [Related]  

  • 17. H(1)- antihistamines and activated blood platelets.
    Petríková M; Jancinová V; Nosál R; Májeková M; Holománová D
    Inflamm Res; 2006 Apr; 55 Suppl 1():S51-2. PubMed ID: 16547813
    [No Abstract]   [Full Text] [Related]  

  • 18. Anti-anaphylactic activity of the novel selective histamine H1 receptor antagonist mizolastine in the rodent.
    Levrier J; Duval D; Prouteau M; Voltz C; Berry CN; Lloyd KG; Scatton B
    Arzneimittelforschung; 1995 May; 45(5):559-68. PubMed ID: 7541995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ketotifen overdose: surveillance of the toxicity of a new drug.
    Jeffreys DB; Volans GN
    Br Med J (Clin Res Ed); 1981 May; 282(6278):1755-6. PubMed ID: 6113023
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacological studies on ticlopidine, a new platelet aggregation inhibitor. Part I: Cardiovascular effects.
    Akashi A; Tamura K; Hirohashi M; Watanabe K; Kasahara A
    Arzneimittelforschung; 1980; 30(3):409-14. PubMed ID: 7387750
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.